Header cover image
  • Investing Ideas
  • /
  • Norwegian Pharmaceuticals & Biotech High ROE Growth Engines

Norwegian Pharmaceuticals & Biotech High ROE Growth Engines

Results

1

0 new

1 companies

Vistin Pharma

Market Cap: NOK 1.1b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 23.80

7D

-2.5%

1Y

2.1%